Supremes debate human gene patents, but are they too late?

gene popup

The following is an edited excerpt.

The Supreme Court is poised to take up the highly charged question of whether human genes can be patented. But another question could trump it: Has the field of genetics moved so far so fast that whatever the court decides, it has come too late to the issue?

For one thing, the Myriad patents at issue are due to expire over the next two years. And experts say a relatively small number of other diagnostic tests or drugs are protected by patents on single genes.

Moreover, it will soon be possible to sequence a person’s entire genome for less than the $4,000 that Myriad charges to analyze just two genes, which are called BRCA1 and BRCA2. And whole genome sequencing might not infringe patents on isolated genes.

Read the full article here: Justices Consider Whether Patents on Genes Are Valid

Read more:

Outbreak Daily Digest
Biotech Facts & Fallacies
Talking Biotech
Genetics Unzipped
Infographic: What are mRNA COVID-19 vaccines and how do they work?

Infographic: What are mRNA COVID-19 vaccines and how do they work?

As of 1 December 2020, thirteen vaccines have reached the final stage of testing: where they are being given to ...

Environmental Working Group: EWG challenges safety of GMOs, food pesticide residues

Known by some as the "Environmental Worrying Group," EWG lobbies ...
m hansen

Michael Hansen: Architect of Consumers Union ongoing anti-GMO campaign

Michael K. Hansen (born 1956) is thought by critics to be ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend